West Pharmaceutical Services Quick Ratio 2012-2026 | WST
Historical quick ratio values for West Pharmaceutical Services (WST) over the last 10 years.
| West Pharmaceutical Services Quick Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets - Inventory | Current Liabilities | Quick Ratio |
| 2026-06-30 | $1.36B | $0.64B | 2.12 |
| 2026-03-31 | $1.37B | $0.67B | 2.04 |
| 2025-12-31 | $1.53B | $0.66B | 2.34 |
| 2025-09-30 | $1.39B | $0.64B | 2.18 |
| 2025-06-30 | $1.26B | $0.61B | 2.08 |
| 2025-03-31 | $1.07B | $0.53B | 2.03 |
| 2024-12-31 | $1.16B | $0.55B | 2.11 |
| 2024-09-30 | $1.15B | $0.52B | 2.23 |
| 2024-06-30 | $1.06B | $0.63B | 1.68 |
| 2024-03-31 | $1.26B | $0.65B | 1.95 |
| 2023-12-31 | $1.50B | $0.67B | 2.24 |
| 2023-09-30 | $1.54B | $0.53B | 2.89 |
| 2023-06-30 | $1.43B | $0.51B | 2.79 |
| 2023-03-31 | $1.49B | $0.54B | 2.79 |
| 2022-12-31 | $1.51B | $0.52B | 2.90 |
| 2022-09-30 | $1.32B | $0.46B | 2.89 |
| 2022-06-30 | $1.36B | $0.57B | 2.41 |
| 2022-03-31 | $1.27B | $0.59B | 2.18 |
| 2021-12-31 | $1.36B | $0.59B | 2.30 |
| 2021-09-30 | $1.25B | $0.56B | 2.23 |
| 2021-06-30 | $1.13B | $0.47B | 2.40 |
| 2021-03-31 | $1.02B | $0.48B | 2.11 |
| 2020-12-31 | $1.05B | $0.50B | 2.09 |
| 2020-09-30 | $0.94B | $0.45B | 2.11 |
| 2020-06-30 | $0.84B | $0.38B | 2.23 |
| 2020-03-31 | $0.73B | $0.34B | 2.11 |
| 2019-12-31 | $0.82B | $0.34B | 2.41 |
| 2019-09-30 | $0.77B | $0.34B | 2.31 |
| 2019-06-30 | $0.71B | $0.31B | 2.27 |
| 2019-03-31 | $0.64B | $0.30B | 2.13 |
| 2018-12-31 | $0.68B | $0.28B | 2.40 |
| 2018-09-30 | $0.64B | $0.29B | 2.23 |
| 2018-06-30 | $0.56B | $0.29B | 1.94 |
| 2018-03-31 | $0.53B | $0.26B | 2.00 |
| 2017-12-31 | $0.53B | $0.28B | 1.89 |
| 2017-09-30 | $0.56B | $0.30B | 1.87 |
| 2017-06-30 | $0.51B | $0.29B | 1.75 |
| 2017-03-31 | $0.44B | $0.26B | 1.72 |
| 2016-12-31 | $0.44B | $0.24B | 1.84 |
| 2016-09-30 | $0.46B | $0.24B | 1.93 |
| 2016-06-30 | $0.46B | $0.24B | 1.93 |
| 2016-03-31 | $0.44B | $0.24B | 1.81 |
| 2015-12-31 | $0.49B | $0.31B | 1.57 |
| 2015-09-30 | $0.49B | $0.30B | 1.65 |
| 2015-06-30 | $0.49B | $0.31B | 1.57 |
| 2015-03-31 | $0.44B | $0.30B | 1.49 |
| 2014-12-31 | $0.48B | $0.25B | 1.89 |
| 2014-09-30 | $0.49B | $0.24B | 2.04 |
| 2014-06-30 | $0.50B | $0.22B | 2.25 |
| 2014-03-31 | $0.50B | $0.23B | 2.19 |
| 2013-12-31 | $0.47B | $0.24B | 2.00 |
| 2013-09-30 | $0.47B | $0.25B | 1.89 |
| 2013-06-30 | $0.44B | $0.22B | 2.00 |
| 2013-03-31 | $0.42B | $0.21B | 2.00 |
| 2012-12-31 | $0.40B | $0.26B | 1.51 |
| 2012-09-30 | $0.39B | $0.28B | 1.42 |
| 2012-06-30 | $0.36B | $0.32B | 1.12 |
| 2012-03-31 | $0.35B | $0.30B | 1.14 |
| 2011-12-31 | $0.32B | $0.24B | 1.32 |
| 2011-09-30 | $0.35B | $0.23B | 1.52 |
| 2011-06-30 | $0.35B | $0.19B | 1.81 |
| 2011-03-31 | $0.32B | $0.18B | 1.77 |
| 2010-12-31 | $0.29B | $0.17B | 1.71 |
| 2010-09-30 | $0.29B | $0.16B | 1.85 |
| 2010-06-30 | $0.26B | $0.16B | 1.64 |
| 2010-03-31 | $0.26B | $0.18B | 1.42 |
| 2009-12-31 | $0.27B | $0.17B | 1.57 |
| 2009-09-30 | $0.26B | $0.16B | 1.62 |
| 2009-06-30 | $0.27B | $0.16B | 1.65 |
| 2009-03-31 | $0.24B | $0.14B | 1.70 |
| 2008-12-31 | $0.25B | $0.16B | 1.57 |
| 2008-09-30 | $0.29B | $0.17B | 1.73 |
| 2008-06-30 | $0.32B | $0.18B | 1.77 |
| 2008-03-31 | $0.30B | $0.16B | 1.93 |
| 2007-12-31 | $0.30B | $0.18B | 1.64 |
| 2007-09-30 | $0.32B | $0.16B | 1.95 |
| 2007-06-30 | $0.34B | $0.15B | 2.28 |
| 2007-03-31 | $0.33B | $0.15B | 2.12 |
| 2006-12-31 | $0.18B | $0.16B | 1.17 |
| 2006-09-30 | $0.19B | $0.16B | 1.21 |
| 2006-06-30 | $0.20B | $0.15B | 1.34 |
| 2006-03-31 | $0.18B | $0.13B | 1.33 |
| 2005-12-31 | $0.18B | $0.13B | 1.37 |
| 2005-09-30 | $0.15B | $0.12B | 1.25 |
| 2005-06-30 | $0.19B | $0.11B | 1.69 |
| 2005-03-31 | $0.16B | $0.10B | 1.62 |
| 2004-12-31 | $0.17B | $0.12B | 1.46 |
| 2004-09-30 | $0.16B | $0.11B | 1.50 |
| 2004-06-30 | $0.15B | $0.11B | 1.42 |
| 2004-03-31 | $0.14B | $0.11B | 1.30 |
| 2003-12-31 | $0.17B | $0.12B | 1.42 |
| 2003-09-30 | $0.15B | $0.10B | 1.42 |
| 2003-06-30 | $0.14B | $0.10B | 1.46 |
| 2003-03-31 | $0.13B | $0.09B | 1.40 |
| 2002-12-31 | $0.12B | $0.09B | 1.37 |
| 2002-09-30 | $0.11B | $0.08B | 1.52 |
| 2002-06-30 | $0.11B | $0.08B | 1.35 |
| 2002-03-31 | $0.12B | $0.08B | 1.39 |
| 2001-12-31 | $0.12B | $0.08B | 1.65 |
| 2001-09-30 | $0.14B | $0.10B | 1.40 |
| 2001-06-30 | $0.13B | $0.09B | 1.45 |
| 2001-03-31 | $0.13B | $0.09B | 1.51 |
| 2000-12-31 | $0.12B | $0.07B | 1.75 |
| 2000-09-30 | $0.14B | $0.08B | 1.81 |
| 2000-06-30 | $0.13B | $0.09B | 1.55 |
| 2000-03-31 | $0.15B | $0.13B | 1.13 |
| 1999-12-31 | $0.14B | $0.10B | 1.37 |
| 1999-09-30 | $0.13B | $0.08B | 1.60 |
| 1999-06-30 | $0.14B | $0.08B | 1.74 |
| 1999-03-31 | $0.14B | $0.09B | 1.55 |
| 1998-12-31 | $0.12B | $0.10B | 1.12 |
| 1998-09-30 | $0.14B | $0.09B | 1.55 |
| 1998-06-30 | $0.14B | $0.08B | 1.85 |
| 1998-03-31 | $0.16B | $0.11B | 1.49 |
| 1997-12-31 | $0.13B | $0.06B | 2.28 |
| 1997-09-30 | $0.14B | $0.07B | 2.03 |
| 1997-06-30 | $0.13B | $0.06B | 1.99 |
| 1997-03-31 | $0.12B | $0.07B | 1.77 |
| 1996-12-31 | $0.11B | $0.07B | 1.72 |
| 1996-09-30 | $0.10B | $0.08B | 1.37 |
| 1996-06-30 | $0.10B | $0.07B | 1.47 |
| 1996-03-31 | $0.10B | $0.07B | 1.37 |
| 1995-12-31 | $0.10B | $0.06B | 1.62 |
| 1995-09-30 | $0.11B | $0.06B | 1.68 |
| 1995-06-30 | $0.10B | $0.09B | 1.11 |
| 1995-03-31 | $0.10B | $0.06B | 1.72 |
| 1994-12-31 | $0.10B | $0.09B | 1.14 |
| 1994-09-30 | $0.08B | $0.07B | 1.12 |
| 1994-06-30 | $0.08B | $0.07B | 1.14 |
| 1994-03-31 | $0.07B | $0.06B | 1.28 |
| 1993-12-31 | $0.06B | $0.05B | 1.25 |
| 1993-09-30 | $0.06B | $0.05B | 1.17 |
| 1993-06-30 | $0.07B | $0.06B | 1.17 |
| 1993-03-31 | $0.07B | $0.06B | 1.15 |
| 1992-12-31 | $0.06B | $0.06B | 1.00 |
| 1992-09-30 | $0.06B | $0.07B | 0.85 |
| 1992-06-30 | $0.06B | $0.07B | 0.94 |
| 1992-03-31 | $0.06B | $0.07B | 0.96 |
| 1991-12-31 | $0.06B | $0.07B | 0.90 |
| 1991-09-30 | $0.06B | $0.06B | 0.96 |
| 1991-06-30 | $0.06B | $0.06B | 0.90 |
| 1991-03-31 | $0.06B | $0.07B | 0.91 |
| 1990-12-31 | $0.06B | $0.07B | 0.85 |
| 1990-09-30 | $0.06B | $0.05B | 1.12 |
| 1990-06-30 | $0.06B | $0.06B | 1.10 |
| 1990-03-31 | $0.06B | $0.05B | 1.17 |
| 1989-12-31 | $0.05B | $0.05B | 1.12 |
| 1989-09-30 | $0.06B | $0.05B | 1.24 |
| 1989-06-30 | $0.06B | $0.05B | 1.29 |
| 1989-03-31 | $0.06B | $0.05B | 1.29 |
| 1988-12-31 | $0.05B | $0.04B | 1.24 |
| 1988-09-30 | $0.06B | $0.05B | 1.23 |
| 1988-06-30 | $0.05B | $0.05B | 1.14 |
| 1988-03-31 | $0.05B | $0.05B | 1.11 |
| 1987-12-31 | $0.05B | $0.05B | 1.19 |
| 1987-09-30 | $0.05B | $0.04B | 1.29 |
| 1987-06-30 | $0.05B | $0.04B | 1.26 |
| 1987-03-31 | $0.05B | $0.04B | 1.32 |
| 1986-12-31 | $0.05B | $0.04B | 1.03 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $25.687B | $3.074B |
| West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| McKesson (MCK) | United States | $104.880B | 22.04 |
| Cardinal Health (CAH) | United States | $54.109B | 20.66 |
| Becton Dickinson (BDX) | United States | $51.228B | 14.30 |
| Straumann Holding AG (SAUHY) | Switzerland | $18.592B | 0.00 |
| Align Technology (ALGN) | United States | $10.528B | 16.28 |
| Cooper (COO) | United States | $10.130B | 11.56 |
| Henry Schein (HSIC) | United States | $9.754B | 16.48 |
| Merit Medical Systems (MMSI) | United States | $5.146B | 23.48 |
| DENTSPLY SIRONA (XRAY) | United States | $1.960B | 6.87 |
| CONMED (CNMD) | United States | $1.406B | 9.82 |
| STAAR Surgical (STAA) | United States | $1.125B | 35.07 |
| Pro-Dex (PDEX) | United States | $0.214B | 19.97 |
| Lifevantage (LFVN) | United States | $0.077B | 11.04 |